John Aspegrén

952 total citations
22 papers, 667 citations indexed

About

John Aspegrén is a scholar working on Small Animals, Pulmonary and Respiratory Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, John Aspegrén has authored 22 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Small Animals, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Anesthesiology and Pain Medicine. Recurrent topics in John Aspegrén's work include Veterinary Pharmacology and Anesthesia (11 papers), Prostate Cancer Treatment and Research (8 papers) and Anesthesia and Sedative Agents (5 papers). John Aspegrén is often cited by papers focused on Veterinary Pharmacology and Anesthesia (11 papers), Prostate Cancer Treatment and Research (8 papers) and Anesthesia and Sedative Agents (5 papers). John Aspegrén collaborates with scholars based in Finland, United Kingdom and France. John Aspegrén's co-authors include B.C. McKusick, Petri Bono, Karim Fizazi, Christophe Massard, Mika Mustonen, Teuvo L.J. Tammela, Joanna C. Murrell, L.J. Hellebrekers, Joris H. Robben and Nicholas D. James and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

John Aspegrén

22 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Aspegrén Finland 12 334 220 192 138 110 22 667
W. J. Biewenga Netherlands 10 128 0.4× 72 0.3× 3 0.0× 41 0.3× 35 0.3× 18 270
Charles Cook Mexico 11 11 0.0× 62 0.3× 9 0.0× 39 0.3× 51 0.5× 20 498
George A. Vogler United States 10 60 0.2× 33 0.1× 9 0.0× 86 0.6× 73 0.7× 19 325
Yuyang Zhang China 11 8 0.0× 70 0.3× 16 0.1× 85 0.6× 96 0.9× 34 424
Luiz Balthazar Saldanha Brazil 11 8 0.0× 55 0.3× 11 0.1× 120 0.9× 162 1.5× 27 458
Roger D. Mitty United States 8 7 0.0× 65 0.3× 14 0.1× 230 1.7× 74 0.7× 14 456
P. Bacon United Kingdom 11 19 0.1× 52 0.2× 18 0.1× 21 0.2× 34 0.3× 15 306
Debra F. Anderson United States 19 6 0.0× 349 1.6× 5 0.0× 118 0.9× 155 1.4× 55 912
Mahmoud Seyedsadr United States 15 5 0.0× 128 0.6× 40 0.2× 344 2.5× 55 0.5× 19 865
Paula F. Moon-Massat United States 13 34 0.1× 42 0.2× 3 0.0× 42 0.3× 128 1.2× 34 478

Countries citing papers authored by John Aspegrén

Since Specialization
Citations

This map shows the geographic impact of John Aspegrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Aspegrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Aspegrén more than expected).

Fields of papers citing papers by John Aspegrén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Aspegrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Aspegrén. The network helps show where John Aspegrén may publish in the future.

Co-authorship network of co-authors of John Aspegrén

This figure shows the co-authorship network connecting the top 25 collaborators of John Aspegrén. A scholar is included among the top collaborators of John Aspegrén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Aspegrén. John Aspegrén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aspegrén, John, et al.. (2023). Pregabalin Alleviates Anxiety and Fear in Cats during Transportation and Veterinary Visits—A Clinical Field Study. Animals. 13(3). 371–371. 11 indexed citations
2.
Jones, Robert H., Karim Fizazi, Nicholas D. James, et al.. (2023). Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 27(4). 786–789. 1 indexed citations
3.
Aspegrén, John, et al.. (2022). Nanoparticle-based oral formulation can surprise you with inferior in vivo absorption in humans. European Journal of Pharmaceutics and Biopharmaceutics. 177. 91–99. 4 indexed citations
4.
Lehtimäki, Jyrki, et al.. (2022). Tasipimidine—the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist. European Journal of Pharmacology. 923. 174949–174949. 4 indexed citations
5.
Vjaters, Egils, Karim Fizazi, Nicholas D. James, et al.. (2022). Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 40(6_suppl). 90–90. 1 indexed citations
6.
Aspegrén, John, et al.. (2021). Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats During Transportation—A Pilot Study. Frontiers in Veterinary Science. 8. 711816–711816. 15 indexed citations
7.
Ameratunga, Malaka, Irene Braña, Petri Bono, et al.. (2020). First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours. British Journal of Cancer. 123(12). 1730–1736. 61 indexed citations
8.
Dai, Francesca, et al.. (2020). Use of Detomidine Oromucosal Gel for Alleviation of Acute Anxiety and Fear in Horses: A Pilot Study. Frontiers in Veterinary Science. 7. 573309–573309. 3 indexed citations
9.
Fizazi, Karim, Christophe Massard, Petri Bono, et al.. (2017). Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial. European Urology Focus. 3(6). 606–614. 17 indexed citations
10.
Shore, Neal D., Teuvo L.J. Tammela, Christophe Massard, et al.. (2017). Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials. European Urology Focus. 4(4). 547–553. 27 indexed citations
11.
Jones, Robert H., John Aspegrén, Christophe Massard, et al.. (2016). Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study. European Urology Focus. 2(5). 547–552. 15 indexed citations
12.
Huhtinen, Mirja, et al.. (2015). Randomized Placebo-Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client-Owned Cats. Journal of Veterinary Internal Medicine. 29(3). 786–793. 26 indexed citations
13.
14.
Massard, C., Petri Bono, Peter Langmuir, et al.. (2014). 862 Safety and efficacy of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients: Analysis of data from the ARADES and the ARAFOR trials. European Urology Supplements. 13(1). e862–e862. 2 indexed citations
15.
García, Jorge A., Vesa Kataja, Nicholas D. James, et al.. (2014). Bone and soft tissue response from a phase I/II study with ODM-201 in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(4_suppl). 102–102. 3 indexed citations
16.
Aspegrén, John, et al.. (2010). Bioavailability of detomidine administered sublingually to horses as an oromucosal gel. Journal of Veterinary Pharmacology and Therapeutics. 34(1). 76–81. 25 indexed citations
17.
Robben, Joris H., et al.. (2009). Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs. Veterinary Anaesthesia and Analgesia. 36(4). 369–383. 43 indexed citations
18.
Robben, Joris H., et al.. (2008). Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs. Veterinary Anaesthesia and Analgesia. 35(2). 141–153. 46 indexed citations
19.
20.
McKusick, B.C., et al.. (2006). Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Veterinary Anaesthesia and Analgesia. 33(4). 214–223. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. J. Biewenga Breakdown of academic impact, for papers by Charles Cook Breakdown of academic impact, for papers by George A. Vogler Breakdown of academic impact, for papers by Yuyang Zhang Breakdown of academic impact, for papers by Luiz Balthazar Saldanha Breakdown of academic impact, for papers by Roger D. Mitty Breakdown of academic impact, for papers by P. Bacon Breakdown of academic impact, for papers by Debra F. Anderson Breakdown of academic impact, for papers by Mahmoud Seyedsadr Breakdown of academic impact, for papers by Paula F. Moon-Massat
Rankless by CCL
2026